Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2013 | 1 |
2015 | 1 |
2016 | 1 |
2019 | 1 |
2022 | 1 |
2023 | 2 |
2024 | 0 |
Search Results
5 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Selpercatinib in Patients With RET Fusion-Positive Non-Small-Cell Lung Cancer: Updated Safety and Efficacy From the Registrational LIBRETTO-001 Phase I/II Trial.
J Clin Oncol. 2023 Jan 10;41(2):385-394. doi: 10.1200/JCO.22.00393. Epub 2022 Sep 19.
J Clin Oncol. 2023.
PMID: 36122315
Free PMC article.
Clinical Trial.
Pemetrexed With Platinum Combination as a Backbone for Targeted Therapy in Non-Small-Cell Lung Cancer.
Stinchcombe TE, Borghaei H, Barker SS, Treat JA, Obasaju C.
Stinchcombe TE, et al. Among authors: barker ss.
Clin Lung Cancer. 2016 Jan;17(1):1-9. doi: 10.1016/j.cllc.2015.07.002. Epub 2015 Jul 30.
Clin Lung Cancer. 2016.
PMID: 26340853
Review.
Item in Clipboard
Pemetrexed use in the adjuvant setting for completely resectable non-small-cell lung cancer.
Simon GR, Manegold C, Barker SS, Treat JA, Visseren-Grul C, Obasaju C.
Simon GR, et al. Among authors: barker ss.
Clin Lung Cancer. 2013 Nov;14(6):601-8. doi: 10.1016/j.cllc.2013.06.001. Epub 2013 Aug 6.
Clin Lung Cancer. 2013.
PMID: 23921171
Review.
Item in Clipboard
Incidence and Management of Olaratumab Infusion-Related Reactions.
Van Tine BA, Govindarajan R, Attia S, Somaiah N, Barker SS, Shahir A, Barrett E, Lee P, Wacheck V, Ramage SC, Tap WD.
Van Tine BA, et al. Among authors: barker ss.
J Oncol Pract. 2019 Nov;15(11):e925-e933. doi: 10.1200/JOP.18.00761. Epub 2019 Jul 3.
J Oncol Pract. 2019.
PMID: 31268811
Free PMC article.
Item in Clipboard
Comparative Effectiveness of First-Line Selpercatinib versus Standard Therapies in Patients with RET-Activated Cancers: An Exploratory Interpatient Analysis of LIBRETTO-001.
De Braud F, Deschler-Baier B, Morris JC 3rd, Worden F, Han Y, Kiiskinen U, Jen MH, Barker SS, Szymczak S, Gilligan AM.
De Braud F, et al. Among authors: barker ss.
Cancers (Basel). 2023 Dec 27;16(1):140. doi: 10.3390/cancers16010140.
Cancers (Basel). 2023.
PMID: 38201566
Free PMC article.
Item in Clipboard
Cite
Cite